Try our mobile app

Switch to company model in classical logic    *

General information

Country: IRELAND

Sector: Biotechnology

Amarin Corporation PLC operates as a biopharmaceutical company. The Company commercializes and develops therapeutics to improve cardiovascular helath. Amarin serves patients worldwide.
Website: amarincorp.com



Growth: Good revenue growth rate 19.0%, there is acceleration compared to average historical growth rates -17.3%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -20.5%

Profitability: LTM EBITDA margin is negative, -42.7%. On average the margin is improving steadily. Gross margin is high, +45.7%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.03 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -5.6% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 3 786.5% higher than minimum and 23.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -1.1x by EV / Sales multiple

Key Financials (Download financials)

Ticker: AMRN
Share price, USD:  (0.0%)15.55
year average price 12.29  


year start price 0.54 2025-02-08

min close price 0.40 2025-03-12

max close price 20.25 2025-10-20

current price 15.55 2026-02-07
Common stocks: 20 564 650

Dividend Yield:  0.0%
EV / Sales: 0.2x
Margin (EBITDA LTM / Revenue): -42.7%
Fundamental value created in LTM:
Market Cap ($m): 320
Net Debt ($m): -280
EV (Enterprise Value): 40
Price to Book: 0.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-16reuters.com

US Supreme Court to hear 'skinny label' patent fight involving Amarin

2025-11-09globenewswire.com

New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

2025-10-30zacks.com

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down

2025-10-06zacks.com

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?

2025-09-29seekingalpha.com

Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom

2025-08-31globenewswire.com

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025

2025-08-30globenewswire.com

New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups

2025-08-22zacks.com

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

2025-07-31zacks.com

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises

2025-07-30seekingalpha.com

Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-10-27
acceptedDate 2025-10-29 07:05:49 2025-07-30 07:05:53 2025-03-12 07:05:26 2024-10-30 16:10:24 2024-07-31 07:05:26 2024-05-01 07:05:31 2024-02-29 07:06:26 2023-11-01 07:05:30 2023-08-02 07:06:43 2023-05-03 07:05:36 2023-03-01 07:16:40 2022-10-27 07:07:13 2022-03-01 06:16:02 2021-02-25 06:06:24
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 49M 73M 229M 42M 68M 56M 307M 66M 80M 86M 369M 90M 583M 614M
costOfRevenue 26M 22M 147M 26M 26M 25M 141M 36M 37M 38M 127M 27M 121M 131M
grossProfit 22M 50M 81M 16M 42M 31M 166M 30M 43M 48M 242M 63M 462M 483M
grossProfitRatio 0.457 0.692 0.385 0.622 0.551 0.451 0.532 0.557 0.699
researchAndDevelopmentExpenses 4M 5M 21M 5M 4M 5M 22M 5M 6M 6M 30M 6M 29M 39M
generalAndAdministrativeExpenses 0 24M 73M 18M 18M 19M 89M 21M 19M 27M 119M 26M 142M 113M
sellingAndMarketingExpenses 0 15M 80M 19M 20M 20M 111M 24M 32M 32M 186M 32M 266M 351M
sellingGeneralAndAdministrativeExpenses 20M 39M 152M 37M 39M 40M 200M 45M 51M 60M 304M 59M 408M 463M
otherExpenses 0 23M 0 0 145 000 2M 11M -575 000 3M 624 000 14M 0 14M 104 000
operatingExpenses 24M 66M 173M 41M 43M 45M 233M 51M 57M 65M 348M 65M 451M 502M
costAndExpenses 50M 89M 320M 67M 68M 70M 374M 87M 94M 103M 475M 92M 573M 634M
interestIncome 0 3M 13M 3M 3M 3M 12M 3M 3M 2M 3M 750 000 1M 5M
interestExpense 0 0 7000 0 0 0 8000 0 0 1M 15 000 750 000 129 000 3M
depreciationAndAmortization 867 000 729 000 3M 760 722 761 853 761 564 3M 734 000 732 000 765 000 3M 774 000 3M 2M
ebitda -6M 8M -74M -24M 237 000 -13M -51M -19M -3M -17M -101M 3M 14M -13M
ebitdaratio -0.134 0.103 -0.577 0.004 -0.227 -0.292 -0.039 -0.193 0.029
operatingIncome -2M -16M -92M -25M -524 590 -14M -68M -21M -24M -17M -106M 2M 11M -20M
operatingIncomeRatio -0.035 -0.22 -0.595 -0.008 -0.24 -0.325 -0.299 -0.202 0.02
totalOtherIncomeExpensesNet -6M 3M 15M 3M 3M 5M 14M -1M -7M 3M 2M -6M 789 000 2M
incomeBeforeTax -7M -13M -77M -22M 3M -9M -54M -19M -18M -14M -104M -4M 11M -17M
incomeBeforeTaxRatio -0.152 -0.185 -0.514 0.043 -0.153 -0.285 -0.223 -0.169 -0.043
incomeTaxExpense 377 000 689 000 5M 4M 1M 1M 5M 501 000 -355 000 2M 2M 1M 4M 745 000
netIncome -8M -14M -82M -25M 2M -10M -59M -19M -18M -16M -106M -5M 8M -18M
netIncomeRatio -0.159 -0.194 -0.594 0.023 -0.176 -0.292 -0.219 -0.191 -0.057
eps -0.02 -0.03 -0.2 -0.061 0.004 -0.024 -0.15 -0.047 -0.043 -0.041 -0.26 -0.013 0.02 -0.047
epsdiluted -0.02 -0.03 -0.061 0.004 -0.024 -0.047 -0.043 -0.041 -0.013
weightedAverageShsOut 416M 414M 411M 411M 411M 410M 394M 408M 408M 406M 401M 405M 396M 360M
weightedAverageShsOutDil 416M 414M 411M 411M 411M 410M 408M 408M 408M 406M 401M 405M 402M 382M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-12 2024-02-29 2023-03-01 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 13M 12M 3M 1M 2M
ebit -77M -54M -104M 11M -15M
nonOperatingIncomeExcludingInterest -15M -14M -2M -917 000 -5M
netIncomeFromContinuingOperations -82M -59M -106M 8M -18M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -82M -59M -106M 8M -18M
epsDiluted -0.2 -0.15 -0.26 0.019 -0.05

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-10-27
acceptedDate 2025-10-29 07:05:49 2025-07-30 07:05:53 2025-03-12 07:05:26 2024-10-30 16:10:24 2024-07-31 07:05:26 2024-05-01 07:05:31 2024-02-29 07:06:26 2023-11-01 07:05:30 2023-08-02 07:06:43 2023-05-03 07:05:36 2023-03-01 07:16:40 2022-10-27 07:07:13 2022-03-01 06:16:02 2021-02-25 06:06:24
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 123M 148M 121M 157M 216M 214M 199M 271M 233M 191M 218M 240M 219M 187M
shortTermInvestments 164M 151M 173M 149M 91M 94M 121M 50M 80M 113M 92M 63M 235M 314M
cashAndShortTermInvestments 287M 299M 294M 306M 307M 309M 321M 321M 313M 304M 309M 304M 454M 501M
netReceivables 127M 119M 122M 113M 124M 116M 134M 122M 123M 133M 131M 123M 164M 155M
inventory 185M 171M 166M 224M 239M 255M 259M 254M 227M 226M 229M 228M 235M 189M
otherCurrentAssets 30M 18M 13M 8M 32M 8M 525 000 19M 43M 20M 20M 28M 4M 4M
totalCurrentAssets 628M 607M 595M 650M 702M 688M 725M 718M 706M 684M 689M 687M 879M 879M
propertyPlantEquipmentNet 7M 8M 8M 8M 8M 8M 8M 9M 9M 9M 10M 9M 9M 10M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 14M 15M 16M 17M 18M 19M 19M 20M 20M 21M 22M 22M 24M 14M
goodwillAndIntangibleAssets 14M 15M 16M 17M 18M 19M 19M 20M 20M 21M 22M 22M 24M 14M
longTermInvestments 0 0 0 0 0 0 0 0 67 000 544 000 1M 2M 35M 62M
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 10M 41M 66M 75M 73M 76M 79M 93M 124M 145M 164M 188M 122M 432 000
totalNonCurrentAssets 31M 63M 90M 100M 98M 102M 107M 122M 154M 176M 197M 222M 189M 87M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 660M 670M 685M 751M 800M 790M 832M 839M 860M 860M 886M 908M 1 068M 966M
accountPayables 37M 45M 40M 41M 54M 68M 53M 53M 54M 59M 65M 93M 115M 106M
shortTermDebt 0 0 0 0 0 -2M 0 0 0 0 0 0 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 2M 2M 2M 2M 2M 2M 2M 3M 3M
otherCurrentLiabilities 146M 141M 140M 161M 176M 157M 185M 211M 215M 183M 36M 192M 46M 29M
totalCurrentLiabilities 182M 186M 180M 202M 231M 224M 259M 267M 271M 244M 259M 287M 371M 307M
longTermDebt 7M 7M 0 8M 8M 8M 0 9M 9M 10M 0 10M 0 0
deferredRevenueNonCurrent 0 0 0 0 0 2M 3M 3M 3M 13M 13M 13M 14M 16M
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 -2M 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 12M 12M 12M 9M 9M 11M 9M 7M 7M 9M 8M -62M 8M 6M
totalNonCurrentLiabilities 19M 19M 19M 18M 17M 20M 20M 19M 20M 31M 31M 33M 30M 31M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 7M 8M 8M 8M 8M 9M 9M 9M 10M 10M 10M 9M 9M
totalLiabilities 201M 205M 199M 219M 248M 244M 280M 286M 291M 275M 291M 320M 401M 339M
preferredStock 0 0 0 0 1 0 0 1 0 0 0 0 0 0
commonStock 310M 309M 305M 305M 305M 305M 303M 302M 302M 301M 299M 299M 294M 290M
retainedEarnings -1 706M -1 698M -1 669M -1 620M -1 595M -1 596M -1 586M -1 581M -1 561M -1 544M -1 527M -1 528M -1 421M -1 429M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 -0 0 0 0 0 0 0 0 0
othertotalStockholdersEquity 1 855M 1 854M 1 846M 1 842M 1 838M 1 831M 1 828M 1 827M 1 817M
totalStockholdersEquity 459M 465M 486M 531M 552M 546M 552M 553M 569M 585M 595M 588M 667M 628M
totalEquity 459M 465M 486M 531M 552M 546M 552M 553M 569M 585M 595M 588M 667M 628M
totalLiabilitiesAndStockholdersEquity 660M 670M 751M 800M 790M 839M 860M 860M 908M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 660M 670M 685M 751M 800M 790M 832M 839M 860M 860M 886M 908M 1 068M 966M
totalInvestments 164M 151M 173M 149M 91M 94M 121M 50M 80M 114M 93M 65M 270M 376M
totalDebt 7M 7M 8M 8M 8M 8M 9M 9M 9M 10M 10M 10M 9M 9M
netDebt -116M -141M -113M -149M -208M -206M -191M -262M -224M -182M -208M -231M -211M -178M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-12 2024-02-29 2023-03-01 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 122M 134M 131M 164M 155M
otherReceivables 0 0 0 0 0
prepaids 0 12M 0 22M 31M
totalPayables 40M 53M 65M 115M 106M
otherPayables 0 0 0 0 0
accruedExpenses 0 19M 157M 208M 170M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 8M 9M 10M 9M 9M
treasuryStock -65M -64M -62M -61M -51M
additionalPaidInCapital 1 915M 1 899M 1 885M 1 855M 1 818M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN AMRN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448 897 448
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-10-27
acceptedDate 2025-10-29 07:05:49 2025-07-30 07:05:53 2025-03-12 07:05:26 2024-10-30 16:10:24 2024-07-31 07:05:26 2024-05-01 07:05:31 2024-02-29 07:06:26 2023-11-01 07:05:30 2023-08-02 07:06:43 2023-05-03 07:05:36 2023-03-01 07:16:40 2022-10-27 07:07:13 2022-03-01 06:16:02 2021-02-25 06:06:24
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -8M -14M -82M -25M 2M -10M -59M -19M -18M -16M -106M -5M 8M -18M
depreciationAndAmortization 861 793 729 000 3M 760 722 761 853 761 564 3M 734 000 732 000 765 000 3M 774 000 3M 2M
deferredIncomeTax 0 0 0 0 0 0 0 262 000 13M 0 0 0 0 0
stockBasedCompensation 0 6M 18M 5M 4M 5M 0 4M 2M 6M 0 5M 0 46M
changeInWorkingCapital -7M 25M 36M 19M -8M -7M 51M 23M 23M 4M -104M -19M -116M -54M
accountsReceivables -8M -12M 11M 11M -8M 18M -2M 330 000 11M -2M 33M 21M -8M -39M
inventory 17M 6M 105M 13M 19M 7M 56M 3M 20M 23M -36M 20M -167M -112M
accountsPayables -4M 24M -77M -29M 8M -35M -164 635 -4M 27M -15M -103M -66M 52M 115M
otherWorkingCapital -12M 8M -3M 24M -28M 3M -3M 24M -34M -1M 2M 6M 8M -17M
otherNonCashItems 1M -973 000 -6M -1M -15M 16M 12M -992 000 -14M -907 000 27M 182 000 39M 2M
netCashProvidedByOperatingActivities -13M 17M -31M -2M -3M -13M 7M 7M 7M -7M -180M -18M -67M -22M
investmentsInPropertyPlantAndEquipment 0 0 0 4.502 -4.502 0 -535 065 -1000 -23 000 0 -598 630 0 0 -252 000
acquisitionsNet 0 0 0 0 0 0 0 -31M 23 000 0 0 0 3999.523 0
purchasesOfInvestments -69M -38M -279M -110M -66M -33M -216M -33M -30M -53M -82M -23M -290M -679M
salesMaturitiesOfInvestments 57M 50M 233M -133M 71M 62M 191M 64M 64M 33M 257M 54M 394M 302M
otherInvestingActivites 0 0 187M 5M 29M 31M -23 000 0 0
netCashUsedForInvestingActivites -12M 12M -57M 5M 29M 31M 34M -20M 31M
debtRepayment 0 0 0 0 0 0 0 0 0
commonStockIssued -284.62 57 489 -10 041 122 047 9994.29 -2041.461 243 428 2M 0
commonStockRepurchased 0 0 0 0 -88 000 -1M 0 -279 000 -187 000 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -239 710 -720 489 -68 116 34 000 -1M 4041.461 3572 -2M -156 000
netCashUsedProvidedByFinancingActivities -239 995 -663 000 -67 564 32 749 -1M -277 000 60 000 364 000 -156 000
effectOfForexChangesOnCash 224 337 0 0 0 0 0 71 367 -37M -57M 0 -3198 0 3872 0
netChangeInCash -25M 28M -78M -59M 2M 15M -18M 38M 42M -26M -5M 12M 32M -458M
cashAtEndOfPeriod 123M 148M 121M 157M 216M 214M 200M 271M 234M 192M 218M 244M 223M 191M
cashAtBeginningOfPeriod 148M 120M 200M 216M 214M 200M 218M 234M 192M 218M 223M 232M 191M 648M
operatingCashFlow -13M 17M -31M -2M -3M -13M 7M 7M 7M -7M -180M -18M -67M -22M
capitalExpenditure 4.889 0 0 4.502 -4.502 0 -24 097 -1000 -23 000 0 -1.886 0 2.411 -252 000
freeCashFlow -13M 17M -31M -2M -3M -13M 7M 7M 7M -7M -180M -18M -67M -22M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-12 2024-02-29 2023-03-01 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 0 0
netCashProvidedByInvestingActivities -46M -26M 175M 104M -377M
netDebtIssuance 0 0 0 0 -50M
longTermNetDebtIssuance 0 0 0 0 -50M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 131 055 2M 664 589 5M 0
netCommonStockIssuance 131 055 2M 664 589 5M 0
commonStockIssuance 131 055 2M 664 589 5M 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -2M -2M -1M -10M -9M
netCashProvidedByFinancingActivities -1M 230 891 -378 766 -5M -59M
incomeTaxesPaid 4M 0 0 0 207 000
interestPaid 0 0 0 0 2M

Earning call transcript

2025 q3
2025-10-29 ET (fiscal 2025 q3)
2025 q2
2025-07-30 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-12 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-05-01 ET (fiscal 2024 q1)
2023 q4
2024-02-29 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-10-27 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-10-29 11:05 ET
Amarin reported for 2025 q3
SEC form 8
2025-10-29 11:05 ET
Amarin published news for 2025 q3
SEC form 8
2025-10-29 11:05 ET
Amarin published news for 2025 q3
SEC form 10
2025-07-30 11:05 ET
Amarin reported for 2025 q2
SEC form 8
2025-07-30 11:05 ET
Amarin published news for 2025 q2
SEC form 8
2025-07-30 11:05 ET
Amarin published news for 2025 q2
SEC form 10
2025-05-07 11:05 ET
Amarin reported for 2025 q1
SEC form 8
2025-05-07 11:05 ET
Amarin published news for 2025 q1
SEC form 8
2025-05-07 11:05 ET
Amarin published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Amarin published news for 2025 q1
SEC form 10
2025-03-12 11:05 ET
Amarin reported for 2024 q4
SEC form 8
2025-03-12 11:05 ET
Amarin published news for 2024 q4
SEC form 8
2025-03-12 11:05 ET
Amarin published news for 2024 q4
SEC form 8
2025-03-12 11:05 ET
Amarin published news for 2024 q4
SEC form 10
2025-03-12 00:00 ET
Amarin published news for 2024 q4
SEC form 10
2024-10-30 16:10 ET
Amarin reported for 2024 q3
SEC form 8
2024-10-30 16:10 ET
Amarin published news for 2024 q3
SEC form 8
2024-10-30 16:10 ET
Amarin published news for 2024 q3
SEC form 10
2024-10-30 00:00 ET
Amarin reported for 2024 q3
SEC form 8
2024-07-31 07:05 ET
Amarin published news for 2024 q2
SEC form 8
2024-07-31 07:05 ET
Amarin published news for 2024 q2
SEC form 10
2024-07-31 07:05 ET
Amarin reported for 2024 q2
SEC form 10
2024-07-31 00:00 ET
Amarin published news for 2024 q2
SEC form 8
2024-05-01 07:10 ET
Amarin published news for 2024 q1
SEC form 8
2024-05-01 07:10 ET
Amarin published news for 2024 q1
SEC form 10
2024-05-01 07:05 ET
Amarin reported for 2024 q1
SEC form 10
2024-05-01 00:00 ET
Amarin published news for 2024 q1
SEC form 10
2024-02-29 07:06 ET
Amarin reported for 2023 q4
SEC form 8
2024-02-29 07:05 ET
Amarin published news for 2023 q4
SEC form 8
2024-02-29 07:05 ET
Amarin published news for 2023 q4
SEC form 10
2024-02-29 00:00 ET
Amarin published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Amarin published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Amarin published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Amarin published news for 2023 q4
SEC form 8
2023-11-01 07:05 ET
Amarin published news for 2023 q3
SEC form 10
2023-11-01 07:05 ET
Amarin reported for 2023 q3
SEC form 10
2023-11-01 00:00 ET
Amarin published news for 2023 q3
SEC form 10
2023-08-02 07:06 ET
Amarin reported for 2023 q2
SEC form 6
2023-08-02 07:01 ET
Amarin published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Amarin published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
Amarin published news for 2023 q2
SEC form 6
2023-07-28 18:46 ET
Amarin published news for 2023 q2
SEC form 6
2023-07-24 21:24 ET
Amarin published news for 2023 q2
SEC form 6
2023-07-20 08:31 ET
Amarin published news for 2023 q2
SEC form 6
2023-07-18 16:25 ET
Amarin published news for 2023 q2
SEC form 8
2023-07-18 00:00 ET
Amarin published news for 2023 q2
SEC form 6
2023-06-23 17:25 ET
Amarin published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Amarin published news for 2023 q1
SEC form 10
2023-05-03 00:00 ET
Amarin published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Amarin reported for 2022 q4
SEC form 8
2023-03-01 00:00 ET
Amarin reported for 2022 q4
SEC form 8
2023-01-10 00:00 ET
Amarin published news for 2022 q4
SEC form 10
2022-10-27 00:00 ET
Amarin reported for 2022 q3
SEC form 8
2022-10-27 00:00 ET
Amarin reported for 2022 q3
SEC form 8
2022-08-03 00:00 ET
Amarin reported for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Amarin reported for 2022 q2
SEC form 8
2022-05-04 00:00 ET
Amarin reported for 2022 q1
SEC form 10
2022-05-04 00:00 ET
Amarin reported for 2022 q1
SEC form 8
2022-03-01 00:00 ET
Amarin published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Amarin published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Amarin published news for 2021 q4
SEC form 8
2021-11-03 00:00 ET
Amarin published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
Amarin published news for 2021 q3
SEC form 8
2021-08-05 00:00 ET
Amarin published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Amarin published news for 2021 q2
SEC form 8
2021-04-29 00:00 ET
Amarin published news for 2021 q1
SEC form 10
2021-04-29 00:00 ET
Amarin published news for 2021 q1